The study by Sharma et al. on tumor and serum samples from 100 patients with invasive ductal breast carcinoma (IDC) has investigated the potential of the ABCB1 promoter methylation status as predictive or prognostic marker in breast cancer [152]. This evidence concerns the gene ABCB1 and neoplasm.